OncoLab Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $697K

  • Investors
  • 3

OncoLab General Information

Description

Operator of a biotech company intended to develop next-generation immuno-oncology therapies for hard-to-treat cancers. The company's therapeutic platform is based on antibody-conjugated nanogels with enhanced drug delivery and immune checkpoint inhibition, enabling customers to access more effective, sustainable and targeted cancer treatments.

Contact Information

Website
www.oncolab.co.kr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 194-25 Osongsaengmyeong 1-ro
  • Osong-eup, Heungdeok-gu, Chungcheongbuk-do
  • Cheongju
  • South Korea
+82
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 194-25 Osongsaengmyeong 1-ro
  • Osong-eup, Heungdeok-gu, Chungcheongbuk-do
  • Cheongju
  • South Korea
+82

OncoLab Timeline

20252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoLab Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 11-Nov-2025 $697K Completed Generating Revenue
3. Grant Completed Generating Revenue
2. Accelerator/Incubator 30-Jun-2024 $1.5M $2M Completed Generating Revenue
1. Seed Round 31-May-2024 $500K $500K Completed Generating Revenue
To view OncoLab’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

OncoLab Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OncoLab Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
FuturePlay Venture Capital Minority
Tech Incubator Program for Startup Accelerator/Incubator
BTB Ventures Accelerator/Incubator
To view OncoLab’s complete investors history, request access »

Ready to get started?

Request a free trial

OncoLab FAQs

  • When was OncoLab founded?

    OncoLab was founded in 2024.

  • Where is OncoLab headquartered?

    OncoLab is headquartered in Cheongju, South Korea.

  • What is the size of OncoLab?

    OncoLab has 7 total employees.

  • What industry is OncoLab in?

    OncoLab’s primary industry is Biotechnology.

  • Is OncoLab a private or public company?

    OncoLab is a Private company.

  • What is OncoLab’s current revenue?

    The current revenue for OncoLab is .

  • How much funding has OncoLab raised over time?

    OncoLab has raised $2.7M.

  • Who are OncoLab’s investors?

    FuturePlay, Tech Incubator Program for Startup, and BTB Ventures have invested in OncoLab.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process